Robert A. Anderson - 26 Feb 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role
Director
Signature
/s/ Maria Zannes, as attorney-in-fact Robert Anderson
Issuer symbol
BIAF
Transactions as of
26 Feb 2024
Transactions value $
$74,899
Form type
4
Filing time
29 Mar 2024, 16:52:15 UTC
Previous filing
24 Jan 2024
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIAF Common Stock Options Exercise $74.9K +64.8K +113.75% $1.16 122K 26 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIAF Stock Option (right to buy) Options Exercise $0 -64.8K -100% $0.00* 0 26 Feb 2024 Common Stock 64.8K $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested in 7 equal monthly installments beginning on May 28, 2014 and the balance of such option vested on December 28, 2014.